FindTrial
Sign In

Safety and outcome of direct retrograde cholangioscopy (DRC) using an ultra-Slim endoscope prototype and peroral cholangioscopy using a direct visualization system via the working channel of a duodenoscope

Safety and outcome of direct retrograde cholangioscopy (DRC) using an ultra-Slim endoscope prototype and peroral cholangioscopy using a direct visualization system via the working channel of a duodenoscope

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00015905
Enrollment
90
Registered
2018-11-14
Start date
2018-11-08
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C22.1 C24.0

Interventions

Group 1: all patients in the time period who underwent cholangioscopy during routine clinical practice

Sponsors

Robert Bosch Medizinische Forschung (RBMF) des Robert Bosch Krankenhaus Stuttgart
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: no additional criteria

Exclusion criteria

Exclusion criteria: no additional criteria

Design outcomes

Primary

MeasureTime frame
Complications after cholangioscopy defined as air embolism, cholangitis, pancreatitis, bleeding, hypoxia or malign arrhythmias—

Secondary

MeasureTime frame
1. technical evaluation regarding sight, advance, controallability, technical success 2. clinical success of an intended intervention (biopsy, ectomy, APC, laser, EHL)—

Countries

Germany

Contacts

Public ContactManuel Pagitz

Robert Bosch Krankenhaus Stuttgart

manuel.pagitz@rbk.de071181015873

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026